DE GARIDEL MARC (Chief Executive Officer) received a stock award from CINCOR PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/30/2023ACC: 0001209191-23-005596
DirectorOfficer· Chief Executive Officer
Since Jan 2022
+200K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
200K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+200K
Price / share
—
Trade value
—
% of position
1600.0%
1/26/2023
12.50K→212.50K
Total
Net shares
+200K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/26/2023 | A · Award | +200K | — | — | 1600.0% | 12.50K | 212.50K |
| Total | +200K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported